Dexelance Balance Sheet Health
Financial Health criteria checks 2/6
Dexelance has a total shareholder equity of €154.8M and total debt of €144.9M, which brings its debt-to-equity ratio to 93.6%. Its total assets and total liabilities are €470.1M and €315.3M respectively. Dexelance's EBIT is €30.0M making its interest coverage ratio 2.7. It has cash and short-term investments of €31.8M.
Key information
93.6%
Debt to equity ratio
€144.95m
Debt
| Interest coverage ratio | 2.7x |
| Cash | €31.84m |
| Equity | €154.83m |
| Total liabilities | €315.31m |
| Total assets | €470.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DEX's short term assets (€157.9M) exceed its short term liabilities (€127.7M).
Long Term Liabilities: DEX's short term assets (€157.9M) do not cover its long term liabilities (€187.6M).
Debt to Equity History and Analysis
Debt Level: DEX's net debt to equity ratio (73.1%) is considered high.
Reducing Debt: Insufficient data to determine if DEX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: DEX's debt is well covered by operating cash flow (25.3%).
Interest Coverage: DEX's interest payments on its debt are not well covered by EBIT (2.7x coverage).